过继免疫治疗
离体
免疫疗法
癌症免疫疗法
过继性细胞移植
免疫学
癌症研究
淋巴因子激活杀伤细胞
自然杀伤细胞
生物
白细胞介素21
体内
T细胞
体外
免疫系统
细胞毒性T细胞
生物技术
生物化学
作者
Natalia Lapteva,Susann Szmania,Frits van Rhee,Cliona M. Rooney
标识
DOI:10.1615/critrevoncog.2014010931
摘要
Natural killer (NK) cells have been shown to have important functions in anti-tumor responses and therefore have been used as adoptive immunotherapy for cancer. Here, we review the current methods of ex vivo activation, enrichment, expansion, and shipment of clinical NK cell products.
科研通智能强力驱动
Strongly Powered by AbleSci AI